
antibodies


Further illnesses still expected from SARS-CoV-2

Memory killer T cells at lower frequency

Cancer Treatment influences vaccine response

Covid-19: herd immunity in Sweden fails to materialise

Covid-19: Not all patients develop protective antibodies

Engineered antibodies from llamas neutralise COVID-19 virus
